The surge in H1N1 viral infections in Delhi this yr is robust sufficient to demand consideration. It’s not, nevertheless, proof of a brand new or unusually deadly virus. That distinction issues. The state authorities put the variety of H1N1 circumstances as of August 27 at 2,729, out of three,736 influenza A and B circumstances recorded total. Influenza A accounted for 3,447 circumstances, of which H1N1 is a subtype that accounted for nearly four-fifths. The H1N1 pressure, which has circulated amongst people since 2009, has since grow to be established as a seasonal influenza virus.
Nonetheless, the size and nature of this yr’s outbreak makes it stand out. Final yr, one other influenza A subtype—H3N2—was extra distinguished in Delhi. And the Indian Council of Medical Analysis has discovered no proof but of a brand new menace or an uncommon genetic shift within the H1N1 to make it extra virulent. That leaves a query Delhi has lengthy been reluctant to confront: why does a metropolis that is aware of influenza recurs yearly proceed to deal with every rise in circumstances as an administrative shock?
Influenza viruses hold evolving, making annual vaccination the sensible means of lowering the danger of great sickness. The vaccine composition advisable by the World Well being Group for the 2026-27 season within the northern hemisphere contains an up to date H1N1 element. It could not stop each an infection, however it may scale back the danger of extreme illness, significantly amongst these most susceptible. That implies a coverage Delhi ought to have had years in the past: an annual influenza programme, with vaccination provided earlier than the seasonal rise to older folks, pregnant ladies, younger youngsters and other people with power diseases—accompanied by systematic surveillance. Influenza is often self-limiting, however in these in danger it may result in pneumonia, respiratory problems and, in extreme circumstances, hospitalisation or loss of life.
